Dr. Charles Kellogg Anderson, MD

Dr. Anderson practices at Willamette Valley Cancer Institute and Research Center in Eugene, Oregon.

Dr. Anderson's NPI, 1215191259, was assigned on July 17, 2008. Dr. Anderson holds Oregon license MD161964.

Dr. Anderson's primary practice is Willamette Valley Cancer Institute and Research Center, at 520 Country Club Rd, Eugene, OR 97401 in Lane County. The practice phone is (541) 683-5001.

Dr. Anderson's primary practice is Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. Dr. Anderson is also affiliated with PeaceHealth Sacred Heart Medical Center RiverBend. The medical group on file is Willamette Valley Cancer Institute & Research Center. Dmand AI also links Dr. Anderson to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Anderson's licenses on file in 2 states: Oregon and Illinois.

CMS data shows 27,388 Medicare services from Dr. Anderson across 30 procedure codes in 2024, for 268 Medicare patients. Medicare paid $150,679 for them.

CMS counts 268 Medicare patients who saw Dr. Anderson in 2024. The largest group is 65 to 74, with 142 patients. 63% of them have high blood pressure, and 55% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 64, with 99% women.

In 2024, Dr. Anderson wrote 400 Medicare Part D claims for 131 patients. 84% of them were for generic drugs. CMS names the drug for 279 of them, across 11 drugs with 11 or more claims each, at $449,434 in total drug cost. In 2023, CMS named 299 claims across 9 drugs.

Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth. CMS counts 19 procedures of removal of the uterus by Dr. Anderson, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Anderson, published from 2012 to 2025. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Drug Resistance, Neoplasm. Dr. Anderson's most frequent co-authors are Kian Behbakht, MD, Patricia S. Braly, MD and Susan Davidson, MD.

Dmand AI links Dr. Anderson to 10 clinical trials, 5 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Ovarian Neoplasms, Fallopian Tube Diseases and Uterine Cervical Neoplasms. AbbVie sponsors the most, 2.

CMS Open Payments shows 110 general payments to Dr. Anderson from 16 drug and device companies from 2016 to 2025. Education make up the largest share, 42% of the total. Intuitive Surgical, Inc. paid the most, $17,658. It also lists 11 research payments totaling $7,684 from 2018 to 2021.